Work

Phase II Trial of Carboplatin, Paclitaxel, Cetuximab, and Bevacizumab Followed by Cetuximab and Bevacizumab in Advanced Nonsquamous Non–Small-Cell Lung Cancer: SWOG S0536

Year: 2013

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0000000000000009

Authors: Edward S. Kim, James Moon, Roy S. Herbst, Mary W. Redman, Shaker R. Dakhil, Mario R. Velasco, Fred R. Hirsch, Philip C. Mack, Karen Kelly, John V. Heymach, David R. Gandara

Institutions: Yale Cancer Center, Levine Cancer Institute, Cancer Center of Kansas, University of Colorado Cancer Center, University of Colorado Anschutz, University of California, Davis, SWOG Cancer Research Network, Cancer Care Specialists of Illinois, UC Davis Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Health and Human Services, Bristol-Myers Squibb, National Institutes of Health, National Cancer Institute

Awards: G1063390784, G117886320, G1188137174, G1205502904, G1216887118, G1343089328, G1375689152, Columbus Community Clinical Oncology Program (Columbus CCOP), G1469275664, G1545560008, U10 Full Member Application Affiliated with SWOG, G1646027999, G1790576020, G1958973285, G1985252453, G1990518739, G2003196729, G2009210887, G2057923966, G2064543036, Scott & White Community Clinical Oncology Program, G2160369479, G2276667821, G2345882982, G2397742718, G2419449687, G2435896781, G2562936776, G2734683319, G2750730928, Ozark Health Ventures, LLC dba Cancer Research for the Ozarks, GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, G3126600779, G3144944009, G3204966229, UCDCCC NCTN U10 Program, G3239274266, G3242537740, Southeast Cancer Control Consortium, Inc, G3295642875, G3334379738, G3350348941, G3484997517, G3647597407, G36541222, G3710026009, G3717912310, G3737421695, G3792990546, G379387698, G3827208107, G3873422784, G3939550896, G398851121, G4094841028, G413878341, Southwest Oncology Group, G4292856267, G4499432180, G4527800867, G4916734862, G4935167430, G5125348268, G5415431867, G5504618518, G609758592, G6109875642, SOUTHWEST ONCOLOGY GROUP, G6211207823, G6290519354, G6723594983, SOUTHWEST ONCOLOGY GROUP, G6782300252, G691096829, G7061256793, CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM, G7520596819, G763325562, G7677205365, G7696306938, G774431799, G776903742, G7772521268, G7860541851, G7939453469, G8006406963, G8413228103, G8593264226, G8623336158, G8740717309, G8777682367, G8937348795, Cancer Center Support Grant P30, University of Colorado Cancer Center Support Grant, G924713883, G937543590, G960417071, G971274320

OpenAlex ID: W2139697170

FWCI: 1.946

Cites: 25

Cited by: 32

Related to: 10